ジスキネジア(Dyskinesia):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Dyskinesia Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dyskinesia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Dyskinesia 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Dyskinesia Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Dyskinesia 34
Feb 09, 2015: Adamas Pharmaceuticals’ Phase 2/3 Clinical Study Published in Movement Disorders 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Neurocrine Biosciences, Inc. 37
Clinical Trial Overview of Neurocrine Biosciences, Inc. 37
Allergan, Inc. 38
Clinical Trial Overview of Allergan, Inc. 38
Merz Pharma GmbH & Co. KgaA 39
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Auspex Pharmaceuticals, Inc. 41
Clinical Trial Overview of Auspex Pharmaceuticals, Inc. 41
UCB S.A. 42
Clinical Trial Overview of UCB S.A. 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
E. Merck KG 44
Clinical Trial Overview of E. Merck KG 44
Adamas Pharmaceuticals, Inc. 45
Clinical Trial Overview of Adamas Pharmaceuticals, Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
National Institute of Neurological Disorders and Stroke 46
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 46
University Health Network 47
Clinical Trial Overview of University Health Network 47
University of Florida 48
Clinical Trial Overview of University of Florida 48
Oregon Health & Science University 49
Clinical Trial Overview of Oregon Health & Science University 49
Leiden University Medical Center 50
Clinical Trial Overview of Leiden University Medical Center 50
Rush University Medical Center 51
Clinical Trial Overview of Rush University Medical Center 51
Seoul National University Hospital 52
Clinical Trial Overview of Seoul National University Hospital 52
Taoyuan Mental Hospital 53
Clinical Trial Overview of Taoyuan Mental Hospital 53
University of Iowa 54
Clinical Trial Overview of University of Iowa 54
Vanderbilt University 55
Clinical Trial Overview of Vanderbilt University 55
Five Key Clinical Profiles 56
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 100


【レポート販売概要】

■ タイトル:ジスキネジア(Dyskinesia):世界の治験レビュー(2015年上半期版)
■ 英文:Dyskinesia Global Clinical Trials Review, H1, 2015
■ 発行日:2015年2月27日
■ 調査会社:GlobalData
■ 商品コード:GDHC2577CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。